Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells

Advances in Pharmacological Sciences

Volumn 2014, Issue , 2014, Pages

  Duval, Florent ^a   Moreno Cuevas, Jorge E ^a   González Garza, Maria Teresa ^a   Rodríguez Montalvo, Carlos ^b   Cruz Vega, Delia Elva ^a  

^a ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^b HOSPITAL SAN JOSÉ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; PLANT EXTRACT;

APOPTOSIS; CELL DEATH; CELL PHAGOCYTOSIS; CELL PROTECTION; DRUG MECHANISM; HUMAN; LIVER CELL; LIVER FIBROSIS; LIVER PROTECTION; MEDICINAL PLANT; NONHUMAN; PATHOGENESIS; REVIEW; STELLATE CELL; TARGET CELL;

EID: 84914680177     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2014/373295     Document Type: Review

References (99)

1. Mormone E., George J., Nieto N., Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chemico-Biological Interactions 2011 193 3 225 231 10.1016/j.cbi.2011.07.001 2-s2.0-80052707667
2. Ellis E. L., Mann D. A., Clinical evidence for the regression of liver fibrosis. Journal of Hepatology 2012 56 5 1171 1180 10.1016/j.jhep.2011.09.024 2-s2.0-84859590655
3. Sánchez-Valle V., Chávez-Tapia N. C., Uribe M., Méndez-Sánchez N., Role of oxidative stress and molecular changes in liver fibrosis: a review. Current Medicinal Chemistry 2012 19 28 4850 4860 10.2174/092986712803341520 2-s2.0-84870461648
4. Friedman S. L., Liver fibrosis-from bench to bedside. Journal of Hepatology 2003 38 supplement 1 S38 S53 2-s2.0-0037220482
5. Poynard T., Mathurin P., Lai C.-L., Guyader D., Poupon R., Tainturier M.-H., Myers R. P., Muntenau M., Ratziu V., Manns M., Vogel A., Capron F., Chedid A., Bedossa P., A comparison of fibrosis progression in chronic liver diseases. Journal of Hepatology 2003 38 3 257 265 10.1016/S0168-8278(02)00413-0 2-s2.0-0037335133
6. Lim Y.-S., Kim W. R., The global impact of hepatic fibrosis and end-stage liver disease. Clinics in Liver Disease 2008 12 4 733 746 10.1016/j.cld.2008.07.007 2-s2.0-54549119175
7. Reeves H. L., Friedman S. L., Activation of hepatic stellate cells-a key issue in liver fibrosis. Frontiers in Bioscience 2002 7 d808 d826 10.2741/reeves 2-s2.0-0036551274
8. Henderson N. C., Iredale J. P., Liver fibrosis: cellular mechanisms of progression and resolution. Clinical Science 2007 112 5-6 265 280 10.1042/CS20060242 2-s2.0-33847367730
9. Duval F., Moreno-Cuevas J. E., González-Garza M. T., Rodríguez-Montalvo C., Cruz-Vega D. E., Liver fibrosis and mechanisms of the protective action of medicinal plants-targeting hepatic stellate cell activation and extracellular matrix deposition. Chinese Medicine. In press
10. Friedman S. L., Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiological Reviews 2008 88 1 125 172 10.1152/physrev.00013.2007 2-s2.0-35948954244
11. Friedman S. L., Mechanisms of hepatic fibrogenesis. Gastroenterology 2008 134 6 1655 1669 10.1053/j.gastro.2008.03.003 2-s2.0-42949163491
12. Mann D. A., Marra F., Fibrogenic signalling in hepatic stellate cells. Journal of Hepatology 2010 52 6 949 950 10.1016/j.jhep.2010.02.005 2-s2.0-77952424205
13. Rockey D. C., Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clinical Gastroenterology and Hepatology 2013 11 3 224.e5 231.e5 10.1016/j.cgh.2013.01.005 2-s2.0-84874574154
14. Rockey D. C., Current and future anti-fibrotic therapies for chronic liver disease. Clinics in Liver Disease 2008 12 4 939 962 10.1016/j.cld.2008.07.011 2-s2.0-54549119172
15. Wells R. G., Cellular sources of extracellular matrix in hepatic fibrosis. Clinics in Liver Disease 2008 12 4 759 768 10.1016/j.cld.2008.07.008 2-s2.0-54549092104
16. Pradere J.-P., Kluwe J., de Minicis S., Jiao J.-J., Gwak G.-Y., Dapito D. H., Jang M.-K., Guenther N. D., Mederacke I., Friedman R., Dragomir A.-C., Aloman C., Schwabe R. F., Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 2013 58 4 1461 1473 10.1002/hep.26429 2-s2.0-84884984479
17. Oakley F., Meso M., Iredale J. P., Green K., Marek C. J., Zhou X., May M. J., Millward-Sadler H., Wright M. C., Mann D. A., Inhibition of inhibitor of b kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 2005 128 1 108 120 10.1053/j.gastro.2004.10.003 2-s2.0-11144325650
18. Elsharkawy A. M., Oakley F., Mann D. A., The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005 10 5 927 939 10.1007/s10495-005-1055-4 2-s2.0-24644488751
19. Iredale J. P., Benyon R. C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., Arthur M. J. P., Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. The Journal of Clinical Investigation 1998 102 3 538 549 10.1172/JCI1018 2-s2.0-0032146551
20. Murphy F. R., Issa R., Zhou X., Ratnarajah S., Nagase H., Arthur M. J. P., Benyon C., Iredale J. P., Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition. Implications for reversibility of liver fibrosis. The Journal of Biological Chemistry 2002 277 13 11069 11076 10.1074/jbc.M111490200 2-s2.0-0037192866
21. Fallowfield J. A., Therapeutic targets in liver fibrosis. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2011 300 5 G709 G715 10.1152/ajpgi.00451.2010 2-s2.0-79955552389
22. Luo Y.-J., Yu J.-P., Shi Z.-H., Wang L., Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats. World Journal of Gastroenterology 2004 10 7 1037 1042 2-s2.0-1842666847
23. Qu Y., Chen W.-H., Zong L., Xu M.-Y., Lu L.-G., 18 α -Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells. Medical Science Monitor 2012 18 1 BR24 BR32 2-s2.0-84855279840
24. Li X., Peng X.-D., Zhang W.-L., Dai L.-L., Inhibiting effects of denshensu, baicalin, astragalus and Panax notoginseng saponins on hepatic fibrosis and their possible mechanisms. Zhonghua Gan Zang Bing Za Zhi 2008 16 3 193 197 2-s2.0-69049119273
25. Xu J., Fu Y., Chen A., Activation of peroxisome proliferator-activated receptor- γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2003 285 1 G20 G30 2-s2.0-0037663778
26. Zheng S., Chen A., Activation of PPAR γ is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochemical Journal 2004 384 1 149 157 10.1042/BJ20040928 2-s2.0-9444252295
27. Zheng S., Chen A., Disruption of transforming growth factor- β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor- γ in rat hepatic stellate cells. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2007 292 1 G113 G123 10.1152/ajpgi.00200.2006 2-s2.0-33846146367
28. Zhou Y., Zheng S., Lin J., Zhang Q.-J., Chen A., The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPAR γ in rat activated hepatic stellate cell in vitro. Laboratory Investigation 2007 87 5 488 498 10.1038/labinvest.3700532 2-s2.0-34247390710
29. Cheng Y., Ping J., Xu L.-M., Effects of curcumin on peroxisome proliferator-activated receptor γ expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Chinese Medical Journal 2007 120 9 794 801 2-s2.0-34248642023
30. Priya S., Sudhakaran P. R., Curcumin-induced recovery from hepatic injury involves induction of apoptosis of activated hepatic stellate cells. Indian Journal of Biochemistry and Biophysics 2008 45 5 317 325 2-s2.0-58149359848
31. Lin Y.-L., Lin C.-Y., Chi N.-W., Huang Y.-T., Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytotherapy Research 2009 23 7 927 932 10.1002/ptr.2764 2-s2.0-67650152203
32. Shin H. W., Park S. Y., Lee K. B., Jang J.-J., Down-regulation of Wnt signaling during apoptosis of human hepatic stellate cells. Hepato-Gastroenterology 2009 56 89 208 212 2-s2.0-64949101091
33. Zhang X.-L., Liu L., Jiang H.-Q., Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation. World Journal of Gastroenterology 2002 8 3 515 519 2-s2.0-0036283099
34. Fang S.-M., Li C.-S., An J.-Y., Dun Z.-N., Yao D.-M., Liu L., Zhang X.-L., The role of extracellular signal-regulated kinase in induction of apoptosis with salvia miltiorrhiza monomer IH764-3 in hepatic stellate cells. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2011 27 4 402 406 2-s2.0-84868596401
35. Liu L., Wei J., Huo X., Fang S., Yao D., Gao J., Jiang H., Zhang X., The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis. Molecular Medicine Reports 2012 6 6 1231 1238 10.3892/mmr.2012.1076 2-s2.0-84868573265
36. Kim J. Y., Kim K. M., Nan J.-X., Zhao Y. Z., Park P.-H., Lee S. J., Sohn D. H., Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. Pharmacology and Toxicology 2003 92 4 195 200 10.1034/j.1600-0773.2003.920410.x 2-s2.0-0037395737
37. Che X.-H., Park E.-J., Zhao Y.-Z., Kim W.-H., Sohn D. H., Tanshinone II A induces apoptosis and s phase cell cycle arrest in activated rat hepatic stellate cells. Basic and Clinical Pharmacology and Toxicology 2010 106 1 30 37 10.1111/j.1742-7843.2009.00465.x 2-s2.0-73649107966
38. Pan T.-L., Wang P.-W., Explore the molecular mechanism of apoptosis induced by tanshinone IIA on activated rat hepatic stellate cells. Evidence-Based Complementary and Alternative Medicine 2012 2012 15 734987 10.1155/2012/734987 2-s2.0-84872775859
39. Lin Y.-L., Lee T.-F., Huang Y.-J., Huang Y.-T., Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. Journal of Pharmacy and Pharmacology 2006 58 7 933 939 10.1211/jpp.58.7.0008 2-s2.0-33745637028
40. Parajuli D. R., Park E.-J., Che X.-H., PF2401-SF, standardized fraction of Salvia miltiorrhiza, induces apoptosis of activated hepatic stellate cells in vitro and in vivo. Molecules 2013 18 2 2122 2134 10.3390/molecules18022122 2-s2.0-84874600944
41. Chor S. Y., Hui A. Y., To K. F., Chan K. K., Go Y. Y., Chan H. L. Y., Leung W. K., Sung J. J. Y., Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. Journal of Ethnopharmacology 2005 100 1-2 180 186 10.1016/j.jep.2005.02.036 2-s2.0-23044482864
42. Chen M. F., Huang C. C., Liu P. S., Chen C. H., Shiu L. Y., Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells. Journal of Medicinal Food 2013 16 9 793 800 10.1089/jmf.2013.2762 2-s2.0-84884506665
43. Park E.-J., Zhao Y.-Z., Kim J., Sohn D. H., A ginsenoside metabolite, 20-O- β -D-glucopyranosyl-20(S)- protopanaxadiol, triggers apoptosis in activated rat hepatic stellate cells via caspase-3 activation. Planta Medica 2006 72 13 1250 1253 10.1055/s-2006-947223 2-s2.0-33751047383
44. Wu Y. L., Wan Y., Jin X. J., Ouyang B. Q., Bai T., Zhao Y. Q., Nan J. X., 25-OCH3-PPD induces the apoptosis of activated t-HSC/Cl-6 cells via c-FLIP-mediated NF- B activation. Chemico-Biological Interactions 2011 194 2-3 106 112 10.1016/j.cbi.2011.08.010 2-s2.0-80054055472
45. Malhi H., Gores G. J., Cellular and molecular mechanisms of liver injury. Gastroenterology 2008 134 6 1641 1654 10.1053/j.gastro.2008.03.002 2-s2.0-42949086433
46. Zhan S.-S., Jiang J. X., Wu J., Halsted C., Friedman S. L., Zern M. A., Torok N. J., Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 2006 43 3 435 443 10.1002/hep.21093 2-s2.0-33645243410
47. Canbay A., Friedman S., Gores G. J., Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004 39 2 273 278 10.1002/hep.20051 2-s2.0-1242336980
48. Canbay A., Taimr P., Torok N., Higuchi H., Friedman S., Gores G. J., Apoptotic body engulfment by a human stellate cell line is profibrogenic. Laboratory Investigation 2003 83 5 655 663 10.1097/01.LAB.0000069036.63405.5C 2-s2.0-0038476330
49. Mehal W., Imaeda A., Cell death and fibrogenesis. Seminars in Liver Disease 2010 30 3 226 231 10.1055/s-0030-1255352 2-s2.0-77954990550
50. Jiang J. X., Venugopal S., Serizawa N., Chen X., Scott F., Li Y., Adamson R., Devaraj S., Shah V., Gershwin M. E., Friedman S. L., Török N. J., Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 2010 139 4 1375 1384 10.1053/j.gastro.2010.05.074 2-s2.0-77957342908
51. Watanabe A., Hashmi A., Gomes D. A., Town T., Badou A., Flavell R. A., Mehal W. Z., Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 2007 46 5 1509 1518 10.1002/hep.21867 2-s2.0-36348997503
52. Sohail M. A., Hashmi A. Z., Hakim W., Watanabe A., Zipprich A., Groszmann R. J., Dranoff J. A., Torok N. J., Mehal W. Z., Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 2009 49 1 185 194 10.1002/hep.22589 2-s2.0-58949088374
53. Jiang J. X., Mikami K., Venugopal S., Li Y., Török N. J., Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF- B-dependent pathways. Journal of Hepatology 2009 51 1 139 148 10.1016/j.jhep.2009.03.024 2-s2.0-67349172516
54. Jiang J. X., Chen X., Serizawa N., Szyndralewiez C., Page P., Schröder K., Brandes R. P., Devaraj S., Török N. J., Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radical Biology & Medicine 2012 53 2 289 296 10.1016/j.freeradbiomed.2012.05.007 2-s2.0-84862290446
55. Ghoneim A. I., Effects of curcumin on ethanol-induced hepatocyte necrosis and apoptosis: implication of lipid peroxidation and cytochrome c. Naunyn-Schmiedeberg's Archives of Pharmacology 2009 379 1 47 60 10.1007/s00210-008-0335-2 2-s2.0-59449089202
56. Qian J.-J., Zhai X.-G., Niu M.-H., Zhou Q., Zhou Y.-J., Curcumin inhibits iron overload-induced hepatocytic apoptosis and nuclear factor- B activity. National Medical Journal of China 2012 92 28 1997 2001 10.3760/cma.j.issn.0376-2491.2012.28.016 2-s2.0-84869217543
57. Kuo J. J., Chang H. H., Tsai T. H., Lee T. Y., Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. International Journal of Molecular Medicine 2012 30 3 643 649 10.3892/ijmm.2012.1020 2-s2.0-84865158452
58. Černý D., Canová N. K., Martínek J., Hořínek A., Kmoníčková E., Zídek Z., Farghali H., Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1. Nitric Oxide-Biology and Chemistry 2009 20 1 1 8 10.1016/j.niox.2008.08.006 2-s2.0-55749097597
59. Ozenirler S., Dincer S., Akyol G., Ozogul C., Oz E., The protective effect of Ginkgo biloba extract on CCI4-induced hepatic damage. Acta Physiologica Hungarica 1997 85 3 277 285 2-s2.0-0031545039
60. Yao P., Li K., Song F., Zhou S., Sun X., Zhang X., Nüssler A. K., Liu L., Heme oxygenase-1 upregulated by Ginkgo biloba extract: potential protection against ethanol-induced oxidative liver damage. Food and Chemical Toxicology 2007 45 8 1333 1342 10.1016/j.fct.2007.01.016 2-s2.0-34447134884
61. 99mTc. Toxicology and Industrial Health 2013 29 1 14 22 10.1177/0748233711433938 2-s2.0-84873808973
62. Yin H.-Q., Kim Y.-S., Choi Y.-J., Kim Y.-C., Sohn D.-H., Ryu S.-Y., Lee B.-H., Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease. Archives of Pharmacal Research 2008 31 5 659 665 10.1007/s12272-001-1209-2 2-s2.0-43749113367
63. Sun R.-F., Liu L.-X., Zhang H.-Y., Effect of tanshinone II on hepatic fibrosis in mice. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009 29 11 1012 1017 2-s2.0-79952672713
64. Zhu B., Zhai Q., Yu B., Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharmaceutical Biology 2010 48 5 484 487 10.3109/13880200903179699 2-s2.0-77951776983
65. Gao Y., Wang N., Zhang Y., Ma Z., Guan P., Ma J., Zhang Y., Zhang X., Wang J., Zhang J., Chu L., Mechanism of protective effects of Danshen against iron overload-induced injury in mice. Journal of Ethnopharmacology 2013 145 1 254 260 10.1016/j.jep.2012.10.060 2-s2.0-84871341598
66. Park E. J., Zhao Y. Z., Kim Y. C., Sohn D. H., PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation. Food and Chemical Toxicology 2007 45 10 1891 1898 10.1016/j.fct.2007.04.005 2-s2.0-34547807118
67. Yin H.-Q., Choi Y.-J., Kim Y.-C., Sohn D.-H., Ryu S.-Y., Lee B.-H., Salvia miltiorrhiza Bunge and its active component cryptotanshinone protects primary cultured rat hepatocytes from acute ethanol-induced cytotoxicity and fatty infiltration. Food and Chemical Toxicology 2009 47 1 98 103 10.1016/j.fct.2008.10.018 2-s2.0-58149182725
68. Oh S.-H., Nan J.-X., Sohn D.-H., Kim Y.-C., Lee B.-H., Salvia miltiorrhiza inhibits biliary obstruction-induced hepatocyte apoptosis by cytoplasmic sequestration of p53. Toxicology and Applied Pharmacology 2002 182 1 27 33 10.1006/taap.2002.9367 2-s2.0-0036073356
69. Yan X., Zhou T., Tao Y., Wang Q., Liu P., Liu C., Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways. Experimental Biology and Medicine 2010 235 5 623 632 10.1258/ebm.2009.009293 2-s2.0-77952556468
70. Tripathi M., Singh B. K., Kakkar P., Glycyrrhizic acid modulates t-BHP induced apoptosis in primary rat hepatocytes. Food and Chemical Toxicology 2009 47 2 339 347 10.1016/j.fct.2008.11.028 2-s2.0-58149488688
71. Guo X.-L., Liang B., Wang X.-W., Fan F.-G., Jin J., Lan R., Yang J.-H., Wang X.-C., Jin L., Cao Q., Glycyrrhizic acid attenuates CCl4-induced hepatocyte apoptosis in rats via a p53-mediated pathway. World Journal of Gastroenterology 2013 19 24 3781 3791 10.3748/wjg.v19.i24.3781 2-s2.0-84879596604
72. Zheng Q.-Z., Lou Y.-J., Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of glycyrrhizin in vitro. Acta Pharmacologica Sinica 2003 24 8 771 777 2-s2.0-0042735041
73. Tang B., Qiao H., Meng F., Sun X., Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats. Brazilian Journal of Medical and Biological Research 2007 40 12 1637 1646 10.1590/S0100-879X2006005000173 2-s2.0-38349188607
74. Ikeda T., Abe K., Kuroda N., Kida Y., Inoue H., Wake K., Morito M., Sato T., The inhibition of apoptosis by glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide/D-galactosamine in mice. Archives of Histology and Cytology 2008 71 3 163 178 10.1679/aohc.71.163 2-s2.0-59949085550
75. Gwak G.-Y., Moon T. G., Lee D. H., Yoo B. C., Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World Journal of Gastroenterology 2012 18 7 679 684 10.3748/wjg.v18.i7.679 2-s2.0-84863153618
76. Gumpricht E., Dahl R., Devereaux M. W., Sokol R. J., Licorice compounds glycyrrhizin and 18 β -glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes. Journal of Biological Chemistry 2005 280 11 10556 10563 10.1074/jbc.M411673200 2-s2.0-15444365508
77. Wu X., Zhang L., Gurley E., Studer E., Shang J., Wang T., Wang C., Yan M., Jiang Z., Hylemon P. B., Sanyal A. J., Pandak W. M. Jr., Zhou H., Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology 2008 47 6 1905 1915 10.1002/hep.22239 2-s2.0-46249130838
78. Liu L.-L., Gong L.-K., Wang H., Xiao Y., Wu X.-F., Zhang Y.-H., Xue X., Qi X.-M., Ren J., Baicalin protects mouse from Concanavalin A-induced liver injury through inhibition of cytokine production and hepatocyte apoptosis. Liver International 2007 27 4 582 591 10.1111/j.1478-3231.2007.01450.x 2-s2.0-34047203049
79. Bhattacharyya S., Pal P. B., Sil P. C., A 35kD Phyllanthus niruri protein modulates iron mediated oxidative impairment to hepatocytes via the inhibition of ERKs, p38 MAPKs and activation of PI3k/Akt pathway. Food and Chemical Toxicology 2013 56 119 130 10.1016/j.fct.2013.02.013 2-s2.0-84875251472
80. Londhe J. S., Devasagayam T. P. A., Foo L. Y., Shastry P., Ghaskadbi S. S., Geraniin and amariin, ellagitannins from Phyllanthus amarus, protect liver cells against ethanol induced cytotoxicity. Fitoterapia 2012 83 8 1562 1568 10.1016/j.fitote.2012.09.003 2-s2.0-84870768499
81. Sarkar M. K., Sil P. C., Prevention of tertiary butyl hydroperoxide induced oxidative impairment and cell death by a novel antioxidant protein molecule isolated from the herb, Phyllanthus niruri. Toxicology in Vitro 2010 24 6 1711 1719 10.1016/j.tiv.2010.05.014 2-s2.0-77956098145
82. Zhu X., Guo X., Mao G., Gao Z., Wang H., He Q., Li D., Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of sirtuin 1. Phytotherapy Research 2013 27 3 417 421 10.1002/ptr.4728 2-s2.0-84874943989
83. Gao H., Zhou Y.-W., Anti-lipid peroxidation and protection of liver mitochondria against injuries by picroside II. World Journal of Gastroenterology 2005 11 24 3671 3674 2-s2.0-23844479597
84. Gao H., Zhou Y.-W., Inhibitory effect of picroside II on hepatocyte apoptosis. Acta Pharmacologica Sinica 2005 26 6 729 736 10.1111/j.1745-7254.2005.00729.x 2-s2.0-20444373022
85. Kim Y.-S., Kim Y.-H., Noh J.-R., Cho E.-S., Park J.-H., Son H.-Y., Protective effect of korean red ginseng against aflatoxin B1-induced hepatotoxicity in rat. Journal of Ginseng Research 2011 35 2 243 249 10.5142/jgr.2011.35.2.243 2-s2.0-79959886636
86. Shi G., Zhang Z., Zhang R., Zhang X., Lu Y., Yang J., Zhang D., Zhang Z., Li X., Ning G., Protective effect of andrographolide against concanavalin A-induced liver injury. Naunyn-Schmiedeberg's Archives of Pharmacology 2012 385 1 69 79 10.1007/s00210-011-0685-z
87. van den Berg R., Haenen G. R. M. M., van den Berg H., Bast A., Transcription factor NF- B as a potential biomarker for oxidative stress. British Journal of Nutrition 2001 86 1 S121 S127 10.1079/BJN2001340 2-s2.0-0034803876
88. van Rossum T. G. J., Vulto A. G., Hop W. C. J., Brouwer J. T., Niesters H. G. M., Schalm S. W., Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. Journal of Gastroenterology and Hepatology (Australia) 1999 14 11 1093 1099 10.1046/j.1440-1746.1999.02008.x 2-s2.0-0032753750
89. van Rossum T. G. J., Vulto A. G., Hop W. C. J., Schalm S. W., Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. The American Journal of Gastroenterology 2001 96 8 2432 2437 10.1016/S0002-9270(01)02612-0 2-s2.0-0034886470
90. Orlent H., Hansen B. E., Willems M., Brouwer J. T., Huber R., Kullak-Ublick G. A., Gerken G., Zeuzem S., Nevens F., Tielemans W. C. M., Zondervan P. E., Lagging M., Westin J., Schalm S. W., Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. Journal of Hepatology 2006 45 4 539 546 10.1016/j.jhep.2006.05.015 2-s2.0-33748120825
91. Manns M. P., Wedemeyer H., Singer A., Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks. Journal of Viral Hepatitis 2012 19 8 537 546 10.1111/j.1365-2893.2011.01579.x 2-s2.0-84863718527
92. Freedman N. D., Curto T. M., Morishima C., Seeff L. B., Goodman Z. D., Wright E. C., Sinha R., Everhart J. E., Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. Alimentary Pharmacology and Therapeutics 2011 33 1 127 137 10.1111/j.1365-2036.2010.04503.x 2-s2.0-78650028517
93. Hawke R. L., Schrieber S. J., Soule T. A., Wen Z., Smith P. C., Reddy K. R., Wahed A. S., Belle S. H., Afdhal N. H., Navarro V. J., Berman J., Liu Q.-Y., Doo E., Fried M. W., Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. Journal of Clinical Pharmacology 2010 50 4 434 449 10.1177/0091270009347475 2-s2.0-77957265017
94. Schrieber S. J., Hawke R. L., Wen Z., Smith P. C., Reddy K. R., Wahed A. S., Belle S. H., Afdhal N. H., Navarro V. J., Meyers C. M., Doo E., Fried M. W., Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metabolism and Disposition 2011 39 12 2182 2190 10.1124/dmd.111.040212 2-s2.0-81855217432
95. Fried M. W., Navarro V. J., Afdhal N., Belle S. H., Wahed A. S., Hawke R. L., Doo E., Meyers C. M., Reddy K. R., Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. Journal of the American Medical Association 2012 308 3 274 282 10.1001/jama.2012.8265 2-s2.0-84863905251
96. Liu P., Hu Y.-Y., Liu C., Zhu D.-Y., Xue H.-M., Xu Z.-Q., Xu L.-M., Liu C.-H., Gu H.-T., Zhang Z.-Q., Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology 2002 8 4 679 685 2-s2.0-0036678553
97. She S.-F., Huang X.-Z., Tong G.-D., Clinical study on treatment of liver fibrosis by different dosages of Salvia injection. Zhongguo Zhong Jie He Za Zhi 2004 24 1 17 20 2-s2.0-3142538801
98. Ye F., Liu Y., Qiu G., Zhao Y., Liu M., Clinical study on treatment of cirrhosis by different dosages of salvia injection. Zhong Yao Cai 2005 28 9 850 854 2-s2.0-33748856416
99. Jin C.-X., Yang J., Sun H.-F., Comparative study of the clinical effects of salvia miltiorrhiza injection and shengmai injection on chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006 26 10 936 938 2-s2.0-39549103728